Low serious infection rates in patients with psoriasis and psoriatic arthritis treated with apremilast for 156 weeks and beyond: Pooled analysis of the phase 3 ESTEEM 1 and 2 and PALACE 1-3 trials Meeting Abstract

sustainable development goals

publication date

  • June 1, 2017

webpage

published in

start page

  • AB162

end page

  • AB162

volume

  • 76

issue

  • 6